Recorded Chinese product: 得力生注射液得力生注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

红参是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:斑蝥Ban Mao、红参Hong Shen、蟾酥Chan Su、黄芪astragalus。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:斑蝥-9bba0ae0成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 得力生注射液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 斑蝥Ban Mao, 红参Hong Shen, 蟾酥Chan Su, 黄芪astragalus.

Explore other medicines containing the same ingredient: 斑蝥 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 得力生注射液Recorded Chinese product: 得力生注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 每支装10ml10 mL per unit

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 北京正邦制药有限公司Chinese legal name: 北京正邦制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z20010135

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z20010135

Manufacturer

Chinese legal name: 北京正邦制药有限公司

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z20010135

生产企业

北京正邦制药有限公司

功能主治

益气扶正,消、散结。用于中、晚期原发性肝癌气虚瘀滞证,症见右肋腹积块、疼痛不移、腹胀食少、倦怠乏力。

用法用量

静脉滴注。将本品40~60ml用500ml5%葡萄糖注射液或氯化钠注射液稀释后使用,滴速以不超过每分钟60滴为宜,一日1次。每疗程首次用量减半,用500ml5%葡萄糖注射液或氯化钠注射液稀释后使用,缓慢滴注,滴速为每分钟不超过15滴,如无不良反应,半小时后可逐渐增加滴速,以不超过每分钟60滴为宜。45日为一疗程,停药一周后可进行下一疗程的治疗,或遵医嘱。

不良反应

本品可能引起肝肾损害,可见恶心、呕吐、腹胀、血尿和蛋白尿等症状,亦可引起尿频、尿急等泌尿系统刺激症状。

禁忌

(1)本品禁止直接静脉推注。|||(2)本品不得与其他药品混合静脉滴注。|||(3)本品严禁不经稀释直接使用。|||(4)本品不得加入滴壶中滴入。

注意事项

(1)用药期间应注意检测肝、肾功能。(2)如果出现泌尿系统不良反应,应停药。再用药时,将本品20-30ml用500ml5%葡萄糖注射液或氯化钠注射液稀释后使用;或减慢滴速,以每分钟不超过40滴为宜;或多饮水。(3)如出现胸闷、心悸、气短等反应,需立即停药,并作相应处理。

贮藏

熔封,避光。

规格

每支装10ml

证据Evidence

  • 批准文号: 国药准字Z20010135
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.